bronchiolus_querschnitt_helmholtz_1920x640px

Immune networks in chronic lung diseases

Fernandez Lab

Our scientific focus is to understand the contribution of the immune system to organ fibrosis. Fibrosis is a common final outcome of most chronic inflammatory diseases, especially chronic lung diseases.

Our scientific focus is to understand the contribution of the immune system to organ fibrosis. Fibrosis is a common final outcome of most chronic inflammatory diseases, especially chronic lung diseases.

Fibrosis - Incurable with limited therapies

To date, as many as 45% of all deaths in the developed world are related to pathological tissue remodeling. Chronic lung diseases (CLD) are the 3rd leading cause of death worldwide. Among CLD, Pulmonary Fibrosis (PF) is a debilitating and incurable disease. Scaring of the lung leads to respiratory failure and 50% of patients die 3-5 years after diagnosis. Our understanding of the pathophysiology of PF is unfortunately limited to established and advanced stages when the extensive lung scaring is irreversible.

Human lung tissue under microscope view.

Project details

  • Functional assessment of interactions between mononuclear myeloid cells and lung structural cells
  • Identification of key ligand/receptor interactions in immune-structural lung cell crosstalk
  • Molecular characterization of in immune-structural lung cell interaction
  • Target evaluation in in-vitro models

Scientists at Fernandez Lab

Asarian_Loredana_LHI_Portrait
Dr. Loredana Asarian

Scientist

Portrait Benteng Deng LHI
Benteng Deng

PhD Student

Porträt Daniela Dietel LHI
Daniela Dietel

Lab Manager

Porträt Subhasree Dutta
Subhasree Dutta

PhD Student

Porträt Wei Han
Wei Han

PhD Student

Porträt Shaoping Hu
Shaoping Hu

PhD Student

Jia_Jianlong_Portrait _LHI_FREI
Jianlong Jia

PhD Student

Li_Shuzhen_Portrait
Shuzhen Li

PhD Student

Paulini_Lara_Portrait
Lara Paulini

PhD Student

Portrait Elisabeth Schindler LHI
Elisabeth Schindler

Technical Assistant

Portrait Dmytro Sirokha LHI
Dmytro Sirokha

PhD Student

Vesa Stana

Doctoral candidate

Publications

Transl. Oncol. 49:102070 (2024)

Jia, J. ; Trassl, L. ; Kong, F. ; Deng, B. ; Liu, R. ; Sun, Z. ; Lan, X. ; Yildirim, A.Ö. ; Stathopoulos, G.T. ; Fernandez, I.E. ; Schamberger, A.C.

Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis.

Mayr, C. ; Sengupta, A. ; Asgharpour, S. ; Ansari, M. ; Pestoni, J. ; Ogar, P. ; Angelidis, I. ; Liontos, A. ; Rodriguez-Castillo, J.A. ; Lang, N.J. ; Strunz, M. ; Porras-Gonzalez, D.L. ; Gerckens, M. ; De Sadeleer, L.J. ; Oehrle, B. ; Viteri-Alvarez, V. ; Fernandez, I.E. ; Tallquist, M. ; Irmler, M. ; Beckers, J. ; Eickelberg, O. ; Stoleriu, M.G. ; Behr, J. ; Kneidinger, N. ; Wuyts, W.A. ; Wasnick, R. ; Yildirim, A.Ö. ; Ahlbrecht, K. ; Morty, R.E. ; Samakovlis, C. ; Theis, F.J. ; Burgstaller, G. ; Schiller, H.

Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts.

Wang, X. ; Zhang, H. ; Wang, Y. ; Bramasole, L. ; Guo, K. ; Mourtada, F. ; Meul, T. ; Hu, Q. ; Viteri-Alvarez, V. ; Kammerl, I.E. ; Königshoff, M. ; Lehmann, M. ; Magg, T. ; Hauck, F. ; Fernandez, I.E. ; Meiners, S.

DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T-cell immunity.
Front. Immunol. 13:901194 (2022)

Alessandrini, F. ; de Jong, R.J. ; Wimmer, M. ; Maier, A.-M. ; Fernandez, I.E. ; Hils, M. ; Buters, J.T.M. ; Biedermann, T. ; Zissler, U.M. ; Hoffmann, C. ; Esser-von Bieren, J. ; Schmidt-Weber, C.B. ; Ohnmacht, C.

Lung epithelial CYP1 activity regulates aryl hydrocarbon receptor dependent allergic airway inflammation.
Cells 11:1341 (2022)

Preisendörfer, S. ; Ishikawa, Y. ; Hennen, E. ; Winklmeier, S. ; Schupp, J.C. ; Knüppel, L. ; Fernandez, I.E. ; Binzenhöfer, L. ; Flatley, A. ; Juan-Guardela, B.M. ; Ruppert, C. ; Guenther, A. ; Frankenberger, M. ; Hatz, R.A. ; Kneidinger, N. ; Behr, J. ; Feederle, R. ; Schepers, A. ; Hilgendorff, A. ; Kaminski, N. ; Meinl, E. ; Bächinger, H.P. ; Eickelberg, O. ; Staab-Weijnitz, C.A.

FK506-binding protein 11 is a novel plasma cell-specific antibody folding catalyst with increased expression in idiopathic pulmonary fibrosis.

Contact

Isis Fernandez Mitarbeiterfoto LHI
Dr. Isis E. Fernandez

Team Leader